Pediatric Cancer Trials: Loyola Receives Grant | Loyola Medicine
Thursday, December 15, 2016

Loyola Receives $50,000 Grant from St. Baldrick's Foundation to Support Pediatric Cancer Clinical Trials

Loyola Medicine nurse with pediatric patient and father

MAYWOOD, IL – Loyola University Chicago Health Sciences Division has received a $50,000 infrastructure grant from St. Baldrick’s Foundation to support pediatric cancer clinical trials.

The grant will help fund a research nurse who coordinates clinical trials of new drugs and drug combinations and new regimens designed to minimize side effects, said Charles Hemenway, MD, PhD, division director of pediatric hematology/oncology of Loyola Medicine and Loyola University Chicago Stritch School of Medicine and the Ronald McDonald House Charities endowed professor in pediatric oncology.

“We are extremely grateful for this generous grant, which will enable us to make more clinical trials available to our patients,” Dr. Hemenway said. “Because government funding is limited, private funding from organizations such as St. Baldrick’s Foundation plays a critical role in advancing the treatment of children with cancer.”

Loyola is among 40 childhood cancer institutions across the country that received infrastructure grants from St. Baldrick’s.

“St. Baldrick’s Foundation is thrilled to fund this latest round of grants, which provides pediatric cancer treatments across the U.S. with the critical support they need to find cures and better treatments,” said St. Baldrick’s CEO Kathleen Ruddy. “With these funds these institutions will be able to enroll more children on lifesaving clinical trials, and complete the studies that are currently in progress. We are very thankful for our dedicated volunteers and donors who make these grants possible.”

The St. Baldrick’s Foundation is the largest private funder of childhood cancer research grants. St. Baldrick’s funds some of the most brilliant childhood cancer research experts in the world who are working to find cures and better treatments for all childhood cancers.

About Loyola Medicine

Loyola Medicine is a member of Trinity Health. Based in the western suburbs of Chicago, LUHS is a quaternary care system that includes Loyola University Medical Center (LUMC), located on a 61-acre campus in Maywood, Gottlieb Memorial Hospital (GMH), on a 36-acre campus in Melrose Park, and convenient locations offering primary and specialty care services throughout Cook, Will and DuPage counties. At the heart of LUMC is a 559-licensed-bed hospital that houses the Center for Heart & Vascular Medicine, the Cardinal Bernardin Cancer Center, a Level 1 trauma center, a burn center, a children's hospital, Loyola Outpatient Center, and Loyola Oral Health Center. The campus also is home to Loyola University Chicago Stritch School of Medicine, Loyola University Chicago Marcella Niehoff School of Nursing and the Loyola Center for Fitness. The GMH campus includes a 255-licensed-bed community hospital, a Professional Office Building with 150 private practice clinics, an adult day care program, the Gottlieb Center for Fitness, the Loyola Center for Metabolic Surgery and Bariatric Care and the Loyola Cancer Care & Research at the Marjorie G. Weinberg Cancer Center at Melrose Park.

Trinity Health is one of the largest multi-institutional Catholic health care delivery systems in the nation. It serves people and communities in 22 states from coast to coast with 93 hospitals, and 120 continuing care locations — including home care, hospice, PACE and senior living facilities — that provide nearly 2.5 million visits annually.